Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP

Watchlist Manager
Tonix Pharmaceuticals Holding Corp Logo
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
Watchlist
Price: 29.2 USD 9.77%
Market Cap: 218.1m USD

Wall Street
Price Targets

TNXP Price Targets Summary
Tonix Pharmaceuticals Holding Corp

There are no price targets for TNXP.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Tonix Pharmaceuticals Holding Corp Competitors:
Price Targets
214450
PharmaResearch Co Ltd
15% Downside
ADMA
ADMA Biologics Inc
29% Upside
AVTE
Aerovate Therapeutics Inc
11% Downside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
29% Upside
PRAX
Praxis Precision Medicines Inc
171% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
65% Upside
RCKT
Rocket Pharmaceuticals Inc
505% Upside
CPRX
Catalyst Pharmaceuticals Inc
40% Upside

Revenue
Forecast

Revenue Estimate
Tonix Pharmaceuticals Holding Corp

The compound annual growth rate of Tonix Pharmaceuticals Holding Corp's revenue for the next 3 years is 137%.

N/A
Past Growth
137%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Tonix Pharmaceuticals Holding Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
Tonix Pharmaceuticals Holding Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TNXP's stock price target?
Not Available

TNXP doesn't have any price targets made by Wall Street professionals.

What is Tonix Pharmaceuticals Holding Corp's Revenue forecast?
Projected CAGR
137%

The compound annual growth rate of Tonix Pharmaceuticals Holding Corp's revenue for the next 3 years is 137%.

Back to Top